Reo Maruyama

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 23

Top Topics

Atrial Fibrillation

High Throughput

Positive Breast Cancer

Top Venues

British journal of cancer

Cancer gene therapy

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, Kenichi Miyata, Alexander D Morris, Kathy Q Cai, Rahul M Prasad, Xueying Ma, Andrey Efimov, Neel Belani, Emily R Gerstein, Yin Fei Tan, Yan Zhou, Jong Wook Kim, Reo Maruyama, Kerry S Campbell, Lu Chen, Yibin Yang, Siddharth Balachandran, Israel Cañadas
Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in Small Cell Lung Cancer. Cancer discovery (2024)
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, Kenichi Miyata, Alexander D Morris, Kathy Q Cai, Rahul M Prasad, Xueying Ma, Andrey Efimov, Neel Belani, Emily R Gerstein, Yin Fei Tan, Yan Zhou, Jong Wook Kim, Reo Maruyama, Kerry S Campbell, Lu Chen, Yibin Yang, Siddharth Balachandran, Israel Cañadas
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer. Cancer discovery 14 (3) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Miwa Tanaka, Surachada Chuaychob, Mizuki Homme, Yukari Yamazaki, Ruyin Lyu, Kyoko Yamashita, Keisuke Ae, Seiichi Matsumoto, Kohei Kumegawa, Reo Maruyama, Wei Qu, Yohei Miyagi, Ryuji Yokokawa, Takuro Nakamura
ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma. Nature communications 14 (1) (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Kenichi Miyata, Xiangyu Zhou, Mika Nishio, Aki Hanyu, Masatomo Chiba, Hiroko Kawasaki, Tomo Osako, Kengo Takeuchi, Sumito Saeki, Takayuki Ueno, Reo Maruyama, Akiko Takahashi
Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America 120 (32) (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Tomoyoshi Nakadai, Miho Shimada, Keiichi Ito, Murat Alper Cevher, Chi-Shuen Chu, Kohei Kumegawa, Reo Maruyama, Sohail Malik, Robert G Roeder
Two target gene activation pathways for orphan ERR nuclear receptors. Cell research 33 (2) (2023)
Kohei Kumegawa, Yoko Takahashi, Sumito Saeki, Liying Yang, Tomoyoshi Nakadai, Tomo Osako, Seiichi Mori, Tetsuo Noda, Sumito Saeki, Takayuki Ueno, Reo Maruyama
GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. NPJ breast cancer 8 (1) (2022)